DZD1516
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DZD1516, covering 2025-04-01 to 2025-04-01. Get the full timeline:
Most recent: Clinical Trial Update: DZD1516 in Combination With Trastuzumab and Capecitabine, or in Combination With T-DM1, in Patients With Metastatic HER2 Positive Breast Cancer [Phase 1]